Search Results

You are looking at 11 - 20 of 70 items for

  • Author: Robert W. Carlson x
  • Refine by Access: All x
Clear All Modify Search
Full access

The NCCN 2021 Virtual Congress: Hematologic Malignancies

Robert W. Carlson

Full access

Industry “Rewrites” of NCCN Guidelines

Robert W. Carlson

Full access

The NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care

Robert W. Carlson

Full access

The NCCN 2019 Annual Congress: Hematologic Malignancies

Robert W. Carlson

Full access

The NCCN 2019 Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care

Robert W. Carlson

Full access

The NCCN 2021 Virtual Annual Conference

Presented by: Robert W. Carlson

Full access

The NCCN 2020 Virtual Annual Conference

Presented by: Robert W. Carlson

Full access

NCCN Evidence Blocks

Robert W. Carlson and Eric Jonasch

NCCN has developed a series of Evidence Blocks: graphics that provide ratings for each recommended treatment regimen in terms of efficacy, toxicity, quality and consistency of the supporting data, and affordability. The NCCN Evidence Blocks are currently available in 10 tumor types within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). At a glance, patients and providers can understand how a given treatment was assessed by the NCCN Guidelines Panel and get a sense of how a given treatment may match individual needs and preferences. Robert W. Carlson, MD, CEO of NCCN, described the reasoning behind this new feature and how the tool is used, and Eric Jonasch, MD, Professor of Genitourinary Medical Oncology at The University of Texas MD Anderson Cancer Center, and Vice Chair of the NCCN Kidney Cancer Panel, described its applicability in the management of metastatic renal cell carcinoma.

Full access

Ten Years of Progress Against Breast Cancer: A Partnership of Basic and Clinical/Translational Science

Robert W. Carlson and on behalf of the NCCN Breast Cancer Panel

Full access

Guidelines for Improving Breast Health Care in Limited Resource Countries: The Breast Health Global Initiative

Benjamin O. Anderson and Robert W. Carlson

Breast cancer is an increasingly urgent problem in low- and mid-level resource regions of the world. Despite knowing the optimal management strategy based on guidelines developed in wealthy countries, clinicians are forced to provide less-than-optimal care when diagnostic or treatment resources are lacking. For this reason, it is important to identify which resources most effectively fill health care needs in limited-resource regions, where patients commonly present with more advanced disease at diagnosis, and to provide guidance on how new resource allocations should be made to maximize improvement in outcome. Established in 2002, the Breast Health Global Initiative (BHGI) created an international health alliance to develop evidence-based guidelines for countries with limited resources to improve breast health outcomes. The BHGI serves as a program for international guideline development and as a hub for linkage among clinicians, governmental health agencies, and advocacy groups to translate guidelines into policy and practice. The BHGI collaborated with 12 national and international health organizations, cancer societies, and nongovernmental organizations to host 2 BHGI international summits. The evidence-based BHGI guidelines, developed at the 2002 Global Summit, were published in 2003 as a theoretical treatise on international breast health care. These guidelines were then updated and expanded at the 2005 Global Summit into a fully comprehensive and flexible framework to permit incremental improvements in health care delivery, based on outcomes, cost, cost-effectiveness, and use of health care services.